Inovio Pharmaceuticals Inc.

INO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.28

+$0.04 (+3.23%)

Sep 22, 2026, 1:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-84.95M	-107.25M	-135.12M	-279.82M	-303.66M	-167.47M
Depreciation & Amortization	2.99M	3.13M	3.5M	5.5M	4.73M	4.63M
Stock-Based Compensation	3.76M	6.6M	11.07M	22.56M	26.34M	15.65M
Other Working Capital	-2.8M	-504.04K	26.4M	-9.07M	13.18M	-2.15M
Other Non-Cash Items	-1.21M	-3.88M	6.47M	11.69M	6.53M	2.36M
Deferred Income Tax	n/a	n/a	-32.05K	4.03M	n/a	37.93M
Change in Working Capital	-9.22M	-2.66M	-10.26M	19.83M	50.35M	-71.07M
Operating Cash Flow	-88.63M	-104.08M	-124.37M	-216.22M	-215.71M	-177.98M
Capital Expenditures	-285.7K	-487.83K	-320.9K	-969.15K	-1.23M	-1.52M
Cash Acquisitions	n/a	n/a	6.22M	-2M	n/a	38.73M
Purchase of Investments	-4.95M	-54.14M	-203.48M	-248.53M	-348.95M	-156.22M
Sales Maturities Of Investments	19.27M	158.64M	284.93M	361.08M	174.84M	62.99M
Other Investing Acitivies	n/a	59.32K	n/a	n/a	n/a	-2.77M
Investing Cash Flow	14.04M	104.07M	87.36M	109.59M	-175.34M	-58.8M
Debt Repayment	n/a	-16.42M	n/a	n/a	n/a	171.62K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-110.78K	-420.8K	-466.65K	-1.11M	2.06M	10.62M
Financial Cash Flow	53.05M	51.48M	5M	81.84M	211.5M	465.28M
Net Cash Flow	-21.54M	51.5M	-32.02M	-24.81M	-179.58M	228.53M
Free Cash Flow	-88.92M	-104.56M	-124.69M	-217.18M	-216.94M	-179.5M
Adj. Free Cash Flow	-92.67M	-111.16M	-135.76M	-239.74M	-243.28M	-195.15M
Maintenance CapEx	-285.7K	-487.83K	-320.9K	n/a	-1.23M	n/a
Growth CapEx	n/a	n/a	n/a	-969.15K	n/a	-1.52M
Owner Earnings	-88.92M	-104.56M	-124.69M	-216.22M	-216.94M	-177.98M